Rocket Lab (NASDAQ:RKLB) Given “Mixed” Rating at Cantor Fitzgerald

Rocket Lab (NASDAQ:RKLB)‘s stock had its “mixed” rating reissued by equities researchers at Cantor Fitzgerald in a research report issued on Thursday, Marketbeat reports. They currently have a $122.00 price target on the rocket manufacturer’s stock. Cantor Fitzgerald’s target price points to a potential upside of 131.22% from the stock’s previous close.

A number of other equities analysts have also recently commented on the company. Berenberg Bank began coverage on Rocket Lab in a report on Wednesday, September 2nd. They set a “buy” rating and a $83.00 price target for the company. Craig Hallum boosted their price target on Rocket Lab from $98.00 to $120.00 and gave the stock a “buy” rating in a report on Monday, June 29th. KGI Securities raised Rocket Lab from a “neutral” rating to an “outperform” rating and set a $107.00 price target for the company in a report on Monday, July 27th. Barclays began coverage on Rocket Lab in a report on Friday, October 9th. They set an “overweight” rating and a $85.00 price target for the company. Finally, Piper Sandler began coverage on Rocket Lab in a report on Wednesday, July 15th. They set a “neutral” rating and a $83.00 price target for the company. Four investment analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Rocket Lab presently has an average rating of “Moderate Buy” and a consensus price target of $104.05.

Rocket Lab Price Performance

Shares of Rocket Lab stock traded down $6.42 during trading on Thursday, reaching $52.76. 27,201,828 shares of the company’s stock were exchanged, compared to its average volume of 22,970,264. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48. Rocket Lab has a 1-year low of $37.57 and a 1-year high of $151.00. The company has a market cap of $31.57 billion, a P/E ratio of -195.75 and a beta of 2.93. The firm’s 50-day moving average price is $69.91 and its 200 day moving average price is $84.33.

Rocket Lab (NASDAQ:RKLB) last posted its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.02). Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%. The business had revenue of $234.07 million for the quarter, compared to analyst estimates of $231.62 million. As a group, research analysts anticipate that Rocket Lab will post -0.20 earnings per share for the current year.

Insider Activity at Rocket Lab

In other news, insider Marvin Clevenger sold 15,051 shares of the business’s stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $69.63, for a total transaction of $1,048,001.13. Following the sale, the insider directly owned 458,924 shares in the company, valued at approximately $31,954,878.12. The trade was a 3.18% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Agostino Ricupati sold 669 shares of the business’s stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $46,582.47. Following the sale, the chief accounting officer owned 26,863 shares in the company, valued at approximately $1,870,470.69. This trade represents a 2.43% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders sold 400,749 shares of company stock valued at $26,964,474. Corporate insiders own 8.40% of the company’s stock.

Institutional Trading of Rocket Lab

Several hedge funds and other institutional investors have recently made changes to their positions in the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new stake in shares of Rocket Lab during the third quarter worth about $446,000. HBW Advisory Services LLC grew its holdings in shares of Rocket Lab by 2.4% during the third quarter. HBW Advisory Services LLC now owns 7,816 shares of the rocket manufacturer’s stock worth $545,000 after purchasing an additional 182 shares during the last quarter. Tempus Wealth Planning LLC increased its stake in shares of Rocket Lab by 3.0% in the third quarter. Tempus Wealth Planning LLC now owns 26,402 shares of the rocket manufacturer’s stock valued at $1,840,000 after buying an additional 768 shares during the period. Sanders Morris Harris LLC increased its stake in shares of Rocket Lab by 7.1% in the third quarter. Sanders Morris Harris LLC now owns 47,078 shares of the rocket manufacturer’s stock valued at $3,479,000 after buying an additional 3,138 shares during the period. Finally, Lodestone Wealth Management LLC increased its stake in shares of Rocket Lab by 17.5% in the third quarter. Lodestone Wealth Management LLC now owns 4,627 shares of the rocket manufacturer’s stock valued at $322,000 after buying an additional 688 shares during the period. 71.78% of the stock is currently owned by institutional investors.

Trending Headlines about Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: TD Cowen reaffirmed its Buy rating with a $90 price target, while Roth Capital maintained a Buy rating with a $110 target. Analysts argue that prioritizing reliability and correcting the manufacturing issue could support Neutron’s long-term prospects. Roth Capital Neutron analysis
• Positive Sentiment: Rocket Lab continues to benefit from strong demand for launch and space systems, including its Electron and HASTE programs. Recent financial information cited approximately $234 million in second-quarter revenue, up about 62% year over year, alongside a substantial backlog and expanding government and defense activity.
• Neutral Sentiment: Cantor Fitzgerald retained a mixed rating but set a $122 price target, suggesting significant longer-term upside if Rocket Lab executes. KeyBanc also advised investors not to panic, though these targets depend heavily on successful Neutron development. Analyst view on Rocket Lab
• Negative Sentiment: Rocket Lab moved Neutron’s maiden flight from the fourth quarter of 2026 to 2027 after identifying manufacturing problems in a forward propellant dome on the first-stage tank. The delay extends the timeline for revenue generation, increases development and cash-burn concerns, and raises questions about program execution. Reuters Neutron launch delay report
• Negative Sentiment: Investors are also weighing recent equity issuance related to the planned Iridium acquisition, lower projected gross margins, and reported insider selling. These factors add dilution and financing overhang to an already volatile, unprofitable stock.

Rocket Lab Company Profile

Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.

Rocket Lab’s primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.